Suppr超能文献

[死后地高辛水平的解读:评估死后血液地高辛浓度的“校正因子”]

[Interpretation of postmortem digoxin levels: evaluating a "corrective factor" for postmortem blood digoxin concentration].

作者信息

Ritz S, Kaatsch H J

机构信息

Abteilung für Rechtsmedizin, Klinikum der Christian-Albrechts-Universitt Kiel, Bundesrepublik Deutschland.

出版信息

Z Rechtsmed. 1990;103(8):573-80. doi: 10.1007/BF01261421.

Abstract

Interpretation of postmortem serum digoxin levels is made difficult above all by a possible prefinal or postmortem rise in digoxin concentrations in the blood. To compensate for this postmortem increase, Eriksson et al. (1984) divided the level of postmortem digoxin in femoral venous blood by a factor of 1.5; in the opinion of these authors, postmortem digoxin levels still exceeding "therapeutic levels" after division by 1.5 are an index of digoxin overdose. The diagnostic value of this "correction factor" was investigated. In 56 cases with documented digoxin medication, samples of postmortem femoral venous blood were taken and the level of digoxin determined. In none of the cases had there been a clinical diagnosis of digoxin intoxication. Fifty percent of the measured values were above "therapeutic levels" (0.7 ng/ml to 2.2 ng/ml). Following division by 1.5, 20% of the cases still showed levels exceeding 2.2 ng/ml; the highest "corrected" value was 4.44 ng/ml. Taking into account the length of time between final dosage and death, individual differences in sensitivity to digitalis glycoside, and the complexity of ante- and postmortem dispersion processes, we concluded for the cases we studied that an (undetected) digoxin overdose was not even likely in those cases whose postmortem values after division by 1.5 lie above "therapeutic levels". The "correction factor" proposed by Eriksson et al. (1984) is only of limited diagnostic value; at best the "corrected" values can give an approximate indication of the corresponding antemortem serum digoxin concentrations. In particular, "corrected" values only a little above "therapeutic levels" could not confirm suspicion of an overdose with sufficient certainty.

摘要

尸体血清地高辛水平的解读尤其困难,因为血液中地高辛浓度可能在死前或死后升高。为了补偿这种死后升高,埃里克森等人(1984年)将股静脉血中死后地高辛水平除以1.5;这些作者认为,除以1.5后死后地高辛水平仍超过“治疗水平”是地高辛过量的指标。对这个“校正因子”的诊断价值进行了研究。在56例有地高辛用药记录的病例中,采集了死后股静脉血样本并测定了地高辛水平。所有病例均无地高辛中毒的临床诊断。50%的测量值高于“治疗水平”(0.7纳克/毫升至2.2纳克/毫升)。除以1.5后,20%的病例仍显示水平超过2.2纳克/毫升;最高“校正”值为4.44纳克/毫升。考虑到末次用药与死亡之间的时间间隔、对洋地黄苷敏感性的个体差异以及生前和死后分布过程的复杂性,我们得出结论,对于我们研究的病例,那些除以1.5后的死后值高于“治疗水平”的病例甚至不太可能存在(未被检测到的)地高辛过量情况。埃里克森等人(1984年)提出的“校正因子”诊断价值有限;充其量,“校正”值只能大致表明相应的生前血清地高辛浓度。特别是,仅略高于“治疗水平”的“校正”值不能足够确定地证实过量用药的怀疑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验